DOCSLIB.ORG

Dichloroacetic Acid (Cas No

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

NTP REPORT ON THE TOXICOLOGY STUDIES OF DICHLOROACETIC ACID (CAS NO. 79-43-6) IN GENETICALLY MODIFIED (FVB Tg.AC HEMIZYGOUS) MICE (DERMAL AND DRINKING WATER STUDIES) AND CARCINOGENICITY STUDIES OF DICHLOROACETIC ACID IN GENETICALLY MODIFIED [B6.129-Trp53tm1Brd (N5) HAPLOINSUFFICIENT] MICE (DRINKING WATER STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 April 2007 NTP GMM 11 NIH Publication No. 07-4428 National Institutes of Health Public Health Service U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES FOREWORD The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Genetically Modified Model (GMM) Report series began in 2005 with studies conducted by the NTP. The studies described in the GMM Report series are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected agents in laboratory animals that have been genetically modified. These genetic modifications may involve inactivation of selected tumor suppressor functions or activation of oncogenes that are commonly observed in human cancers. This may result in a rapid onset of cancer in the genetically modified animal when exposure is to agents that act directly or indirectly on the affected pathway. An absence of a carcinogenic response may reflect either an absence of carcinogenic potential of the agent or that the selected model does not harbor the appropriate genetic modification to reduce tumor latency and allow detection of carcinogenic activity under the conditions of these subchronic studies. Substances selected for NTP toxicity and carcinogenicity studies are chosen primarily on the basis of human exposure, level of production, and chemical structure. The interpretive conclusions presented in NTP GMM Reports are based only on the results of these NTP studies. Extrapolation of these results to other species, including characterization of hazards and risks to humans, requires analyses beyond the intent of these reports. Selection per se is not an indicator of a substance’s carcinogenic potential. The NTP conducts its studies in compliance with its laboratory health and safety guidelines and FDA Good Laboratory Practice Regulations and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use are in accordance with the Public Health Service Policy on Humane Care and Use of Animals. Studies are subjected to retrospective quality assurance audits before being presented for public review. NTP GMM Reports are indexed in the NIH/NLM PubMed database and are available free of charge electronically on the NTP website (http://ntp.niehs.nih.gov) or in hardcopy upon request from the NTP Central Data Management group at [email protected] or (919) 541-3419. NTP REPORT ON THE TOXICOLOGY STUDIES OF DICHLOROACETIC ACID (CAS NO. 79-43-6) IN GENETICALLY MODIFIED (FVB Tg.AC HEMIZYGOUS) MICE (DERMAL AND DRINKING WATER STUDIES) AND CARCINOGENICITY STUDIES OF DICHLOROACETIC ACID IN GENETICALLY MODIFIED [B6.129-Trp53tm1Brd (N5) HAPLOINSUFFICIENT] MICE (DRINKING WATER STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 April 2007 NTP GMM 11 NIH Publication No. 07-4428 National Institutes of Health Public Health Service U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 2 CONTRIBUTORS National Toxicology Program NTP Pathology Working Group Evaluated and interpreted results and reported findings Evaluated slides and prepared pathology report on mice (July 16, 2002) G.A. Boorman, Ph.D., Study Scientist S.D. Rousselle, D.V.M., Chairperson R.A. Herbert, D.V.M., Ph.D., Study Pathologist Pathology Associates, A Charles River Company D.W. Bristol, Ph.D. K.J. Cimon, D.V.M., M.S. J.R. Bucher, Ph.D. Experimental Pathology Laboratories, Inc. L.T. Burka, Ph.D. R.A. Herbert, D.V.M., Ph.D. R.S. Chhabra, Ph.D. National Toxicology Program J.E. French, Ph.D. P.C. Howroyd, M.A., VetMB J.R. Hailey, D.V.M. Experimental Pathology Laboratories, Inc. G.E. Kissling, Ph.D. J. Mahler, D.V.M. A.P. King-Herbert, D.V.M. National Toxicology Program D.E. Malarkey, D.V.M., Ph.D. G. Pearse, B.V.M.&S. R.R. Maronpot, D.V.M. National Toxicology Program J.C. Peckham, D.V.M., M.S., Ph.D. M.K. Vallant, B.S., M.T. Experimental Pathology Laboratories, Inc. S.D. Peddada, Ph.D. D.C. Wolf, D.V.M., Ph.D. C.S. Smith, Ph.D. United States Environmental Protection Agency G.S. Travlos, D.V.M. K.L. Witt, M.S. Constella Group, Inc. Provided statistical analyses Battelle Columbus Operations Principal Investigator Conducted studies and evaluated pathology findings P.W. Crockett, Ph.D., L.J. Betz, M.S. M.R. Hejtmancik, Ph.D., Principal Investigator K.P. McGowan, M.B.A. J.D. Toff, II, D.V.M., M.S. Biotechnical Services, Inc. Experimental Pathology Laboratories, Inc. Prepared Report Provided pathology review S.R. Gunnels, M.A., Principal Investigator M.H. Hamlin, II, D.V.M., Principal Investigator L.M. Harper, B.S. K.J. Cimon, D.V.M., M.S. J.I. Powers, M.A.P. P.C. Howroyd, M.A., VetMB D.C. Serbus, Ph.D. J.C. Peckham, D.V.M., M.S., Ph.D. Dynamac Corporation Prepared quality assurance audits S. Brecher, Ph.D., Principal Investigator 3 CONTENTS ABSTRACT . 5 EXPLANATION OF LEVELS OF EVIDENCE OF CARCINOGENIC ACTIVITY . 11 TECHNICAL REPORTS REVIEW SUBCOMMITTEE . 12 SUMMARY OF TECHNICAL REPORTS REVIEW SUBCOMMITTEE COMMENTS . 13 INTRODUCTION . 15 MATERIALS AND METHODS . 21 RESULTS . 31 DISCUSSION AND CONCLUSIONS . 67 REFERENCES . 71 APPENDIX A Summary of Lesions in Tg.AC Hemizygous Mice in the Dermal Studies of Dichloroacetic Acid . 77 APPENDIX B Summary of Lesions in Tg.AC Hemizygous Mice in the Drinking Water Studies of Dichloroacetic Acid . 95 APPENDIX C Summary of Lesions in p53 Haploinsufficient Mice in the Drinking Water Studies of Dichloroacetic Acid . 113 APPENDIX D Genetic Toxicology . 129 APPENDIX E Hematology Results . 137 APPENDIX F Organ Weights and Organ-Weight-to-Body-Weight Ratios . 141 APPENDIX G Chemical Characterization and Dose Formulation Studies . 149 APPENDIX H Water and Compound Consumption in the 26- and 41-Week Drinking Water Studies of Dichloroacetic Acid . 159 4 Dichloroacetic Acid, NTP GMM 11 SUMMARY Background Dichloroacetic acid is a by-product of water disinfection. We tested if dichloroacetic acid could cause cancer in two different strains of genetically modified mice. Methods We applied solutions containing dichloroacetic acid to the backs of male and female Tg.AC mice for 6 or 9 months and gave dichloroacetic acid dissolved in drinking water to male and female Tg.AC hemizygous mice and to male and female p53 haploinsufficient mice for 6 or 10 months. Animals given plain water served as the control groups. Tissues from 18 sites were examined for every animal. Results Male and female Tg.AC mice with dichloroacetic acid applied to their backs had greatly increased rates of epidermal hyperkeratosis at the site where the chemical was applied, and Tg.AC mice receiving the highest concentrations (0.5 grams per kilogram of body weight each day) developed squamous cell papillomas. In Tg.AC mice receiving dichloroacetic acid in the drinking water, a few alveolar/bronchiolar tumors of the lung were seen in exposed animals in each of the four studies. There were no increases in cancers in the p53 haploinsufficient mice given dichloroacetic acid in the drinking water. Conclusions We conclude that dichloroacetic acid did not cause cancer in the genetically modified p53 haploinsufficient mice and gave only weakly positive responses when given to Tg.AC mice. Dichloroacetic acid did cause cancer in several other long-term studies with different rodents, and thus we conclude these genetically modified mice may not be as sensitive for detecting certain cancer-causing compounds. 5 ABSTRACT O Cl OH Cl DICHLOROACETIC ACID CAS No. 79-43-6 Chemical Formula: C2H2Cl2O2 Molecular Weight: 128.9426 Synonyms: Acetic acid, dichloro; bichloracetic acid; DCA; dichlorethanoic acid; 2,2-dichloroacetic acid; dichloroethanoic acid; kyselina dichloroctova; Urner’s liquid Dichloroacetic acid was nominated for study by the was tested for potential toxicity and carcinogenicity in United States Environmental Protection Agency and by two relatively well-studied models, the Tg.AC hemizy­ the National Institute of Environmental Health Sciences gous strain and the p53 haploinsufficient strain. Male because of its widespread occurrence in drinking water and female Tg.AC hemizygous and p53 haploinsuffi­ as a by-product of water disinfection using chlorination. cient mice were exposed to dichloroacetic acid in the It was also nominated because dichloroacetic acid is the drinking water (greater than 98% pure) for 26 or most studied representative of the class of haloacetic 41 weeks. In addition, male and female Tg.AC hemizy­ acids and has been shown to cause liver tumors in both gous mice were exposed by dermal application for 26 or rats and mice. Haloacetic acids are second only to tri­ 39 weeks. Genetic toxicology studies were conducted in halomethanes as a family of disinfection by-products Salmonella typhimurium strains TA98, TA100, and found in many drinking water supplies.
Recommended publications
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024

    Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024

    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
  • Toxicological Review of Chloral Hydrate (CAS No. 302-17-0) (PDF)

    Toxicological Review of Chloral Hydrate (CAS No. 302-17-0) (PDF)

    EPA/635/R-00/006 TOXICOLOGICAL REVIEW OF CHLORAL HYDRATE (CAS No. 302-17-0) In Support of Summary Information on the Integrated Risk Information System (IRIS) August 2000 U.S. Environmental Protection Agency Washington, DC DISCLAIMER This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. Note: This document may undergo revisions in the future. The most up-to-date version will be made available electronically via the IRIS Home Page at http://www.epa.gov/iris. ii CONTENTS—TOXICOLOGICAL REVIEW for CHLORAL HYDRATE (CAS No. 302-17-0) FOREWORD .................................................................v AUTHORS, CONTRIBUTORS, AND REVIEWERS ................................ vi 1. INTRODUCTION ..........................................................1 2. CHEMICAL AND PHYSICAL INFORMATION RELEVANT TO ASSESSMENTS ..... 2 3. TOXICOKINETICS RELEVANT TO ASSESSMENTS ............................3 4. HAZARD IDENTIFICATION ................................................6 4.1. STUDIES IN HUMANS - EPIDEMIOLOGY AND CASE REPORTS .................................................6 4.2. PRECHRONIC AND CHRONIC STUDIES AND CANCER BIOASSAYS IN ANIMALS ................................8 4.2.1. Oral ..........................................................8 4.2.2. Inhalation .....................................................12 4.3. REPRODUCTIVE/DEVELOPMENTAL STUDIES ..........................13
  • Are There Single-Well Hydrogen Bonds in Pyridine-Dichloroacetic Acid Complexes? Charles L

    Are There Single-Well Hydrogen Bonds in Pyridine-Dichloroacetic Acid Complexes? Charles L

    Supplementary Material (ESI) for Chemical Communications This journal is © The Royal Society of Chemistry 2009 Are There Single-Well Hydrogen Bonds in Pyridine-Dichloroacetic Acid Complexes? Charles L. Perrin* and Phaneendrasai Karri Electronic Supplementary Information EXPERIMENTAL DETAILS Materials. All pyridines, dichloroacetic acid, and dichloroacetic anhydride were purchased from Aldrich Chemical Company. Pyridines were stored over activated 4Å molecular sieves under dry N2 for several days prior to use. NMR solvents CD2Cl2 and CDCl3 and 1-mL ampoules of H218O (97.6 atom% 18O) were purchased from Cambridge Isotope Labs. Preparation of Cl2CHCOOH-18O2. Dichloroacetyl chloride (0.5 mL, 5 mmol) was stirred in an ice bath with 0.3 mL H218O (16 mmol) for 1 hr, then warmed to 25ºC and stirred. Incorporation of 18O label was monitored by mass spectrometry. After 48 hr the peaks of mono-18O and di-18O2 acids had nearly equal intensites, and the ratio did not change further. The stirring was stopped and water and HCl were evaporated under reduced pressure (<1 mm Hg) for 24 hr. The extent of labeling was confirmed by the 13C NMR spectrum of a 2:1 mixture with unlabeled dichloroacetic acid in CDCl3, which showed three peaks of nearly the same intensity. Preparation of NMR Samples. Samples were prepared under inert atmosphere using syringe transfer techniques. Pyridine or a substituted pyridine (1.2 mmol) was added to dichloromethane- d2 (1 g). Dichloroacetic acid-18O2 (10 uL of 1:1 mixture with dichloroacetic acid-18O, 0.06 mmol each) and dichloroacetic acid (5 uL, 0.06 mmol) were added to the solution.
  • Safety Data Sheet (SDS) OSHA Hazcom Standard 29 CFR 1910.1200(G) and GHS Rev 03

    Safety Data Sheet (SDS) OSHA Hazcom Standard 29 CFR 1910.1200(G) and GHS Rev 03

    Page 1/12 Safety Data Sheet (SDS) OSHA HazCom Standard 29 CFR 1910.1200(g) and GHS Rev 03. Reviewed on 09/25/18 Issue date 06/11/15 * 1 Identification ꞏ Product identifier ꞏ Trade name: Dichloroacetic Acid ꞏ CAS Number: 79-43-6 ꞏ EC number: 201-207-0 ꞏ Index number: 607-066-00-5 ꞏ Relevant identified uses of the substance or mixture and uses advised against No further relevant information available. ꞏ Product description Dichloroacetic Acid ꞏ Details of the supplier of the safety data sheet ꞏ Manufacturer/Supplier: Dermatologic Lab & Supply, Inc. 608 13th Ave. Council Bluffs, IA USA 51501-6401 Voice: (800) 831-6273 or (712) 323-3269 Fax: (800) 320-9612 or (712) 323-1156 www.delasco.com ꞏ Emergency telephone number: Chemtrec 800-424-9300 * 2 Hazard(s) identification ꞏ Classification of the substance or mixture GHS08 Health hazard Carc. 2 H351 Suspected of causing cancer. Repr. 1A H360 May damage fertility or the unborn child. GHS05 Corrosion Skin Corr. 1A H314Causes severe skin burns and eye damage. GHS09 Environment Aquatic Acute 1H400Very toxic to aquatic life. ꞏ Label elements ꞏ GHS label elements The substance is classified and labeled according to the Globally Harmonized System (GHS). 41.0 Page 2/12 Safety Data Sheet (SDS) OSHA HazCom Standard 29 CFR 1910.1200(g) and GHS Rev 03. Issue date 06/11/15 Reviewed on 09/25/18 Trade name: Dichloroacetic Acid ꞏ Hazard pictograms GHS05 GHS08 GHS09 ꞏ Signal word Danger ꞏ Hazard-determining components of labeling: Dichloroacetic acid ꞏ Hazard statements Causes severe skin burns and eye damage.
  • APPENDIX G Acid Dissociation Constants

    APPENDIX G Acid Dissociation Constants

    harxxxxx_App-G.qxd 3/8/10 1:34 PM Page AP11 APPENDIX G Acid Dissociation Constants §␮ ϭ 0.1 M 0 ؍ (Ionic strength (␮ † ‡ † Name Structure* pKa Ka pKa ϫ Ϫ5 Acetic acid CH3CO2H 4.756 1.75 10 4.56 (ethanoic acid) N ϩ H3 ϫ Ϫ3 Alanine CHCH3 2.344 (CO2H) 4.53 10 2.33 ϫ Ϫ10 9.868 (NH3) 1.36 10 9.71 CO2H ϩ Ϫ5 Aminobenzene NH3 4.601 2.51 ϫ 10 4.64 (aniline) ϪO SNϩ Ϫ4 4-Aminobenzenesulfonic acid 3 H3 3.232 5.86 ϫ 10 3.01 (sulfanilic acid) ϩ NH3 ϫ Ϫ3 2-Aminobenzoic acid 2.08 (CO2H) 8.3 10 2.01 ϫ Ϫ5 (anthranilic acid) 4.96 (NH3) 1.10 10 4.78 CO2H ϩ 2-Aminoethanethiol HSCH2CH2NH3 —— 8.21 (SH) (2-mercaptoethylamine) —— 10.73 (NH3) ϩ ϫ Ϫ10 2-Aminoethanol HOCH2CH2NH3 9.498 3.18 10 9.52 (ethanolamine) O H ϫ Ϫ5 4.70 (NH3) (20°) 2.0 10 4.74 2-Aminophenol Ϫ 9.97 (OH) (20°) 1.05 ϫ 10 10 9.87 ϩ NH3 ϩ ϫ Ϫ10 Ammonia NH4 9.245 5.69 10 9.26 N ϩ H3 N ϩ H2 ϫ Ϫ2 1.823 (CO2H) 1.50 10 2.03 CHCH CH CH NHC ϫ Ϫ9 Arginine 2 2 2 8.991 (NH3) 1.02 10 9.00 NH —— (NH2) —— (12.1) CO2H 2 O Ϫ 2.24 5.8 ϫ 10 3 2.15 Ϫ Arsenic acid HO As OH 6.96 1.10 ϫ 10 7 6.65 Ϫ (hydrogen arsenate) (11.50) 3.2 ϫ 10 12 (11.18) OH ϫ Ϫ10 Arsenious acid As(OH)3 9.29 5.1 10 9.14 (hydrogen arsenite) N ϩ O H3 Asparagine CHCH2CNH2 —— —— 2.16 (CO2H) —— —— 8.73 (NH3) CO2H *Each acid is written in its protonated form.
  • Evaluating Analytical Methods for Detecting Unknown Chemicals in Recycled Water

    Evaluating Analytical Methods for Detecting Unknown Chemicals in Recycled Water

    PROJECT NO. 4992 Evaluating Analytical Methods for Detecting Unknown Chemicals in Recycled Water Evaluating Analytical Methods for Detecting Unknown Chemicals in Recycled Water Prepared by: Keith A. Maruya Charles S. Wong Southern California Coastal Water Research Project Authority 2020 The Water Research Foundation (WRF) is a nonprofit (501c3) organization which provides a unified source for One Water research and a strong presence in relationships with partner organizations, government and regulatory agencies, and Congress. The foundation conducts research in all areas of drinking water, wastewater, stormwater, and water reuse. The Water Research Foundation’s research portfolio is valued at over $700 million. The Foundation plays an important role in the translation and dissemination of applied research, technology demonstration, and education, through creation of research‐based educational tools and technology exchange opportunities. WRF serves as a leader and model for collaboration across the water industry and its materials are used to inform policymakers and the public on the science, economic value, and environmental benefits of using and recovering resources found in water, as well as the feasibility of implementing new technologies. For more information, contact: The Water Research Foundation Alexandria, VA Office Denver, CO Office 1199 North Fairfax Street, Suite 900 6666 West Quincy Avenue Alexandria, VA 22314‐1445 Denver, Colorado 80235‐3098 Tel: 571.384.2100 Tel: 303.347.6100 www.waterrf.org [email protected] ©Copyright 2020 by The Water Research Foundation. All rights reserved. Permission to copy must be obtained from The Water Research Foundation. WRF ISBN: 978‐1‐60573‐503‐0 WRF Project Number: 4992 This report was prepared by the organization(s) named below as an account of work sponsored by The Water Research Foundation.
  • Chloral Hydrate

    Chloral Hydrate

    NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDY OF CHLORAL HYDRATE (AD LIBITUM AND DIETARY CONTROLLED) (CAS NO. 302-17-0) IN MALE B6C3F1 MICE (GAVAGE STUDY) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 December 2002 NTP TR 503 NIH Publication No. 03-4437 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health FOREWORD The National Toxicology Program (NTP) is made up of four charter agencies of the U.S. Department of Health and Human Services (DHHS): the National Cancer Institute (NCI), National Institutes of Health; the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health; the National Center for Toxicological Research (NCTR), Food and Drug Administration; and the National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention. In July 1981, the Carcinogenesis Bioassay Testing Program, NCI, was transferred to the NIEHS. The NTP coordinates the relevant programs, staff, and resources from these Public Health Service agencies relating to basic and applied research and to biological assay development and validation. The NTP develops, evaluates, and disseminates scientific information about potentially toxic and hazardous chemicals. This knowledge is used for protecting the health of the American people and for the primary prevention of disease. The studies described in this Technical Report were performed under the direction of the NCTR and were conducted in compliance with NTP laboratory health and safety requirements and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use were in accordance with the Public Health Service Policy on Humane Care and Use of Animals.
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0168177 A1 Qin Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2010/0168177 A1 Qin Et Al

    US 20100168177A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0168177 A1 Qin et al. (43) Pub. Date: Jul. 1, 2010 (54) STABLE INSECTICIDE COMPOSITIONS (22) Filed: Dec. 22, 2009 Related U.S. Application Data (75) Inventors: Kuide Qin, Westfield, IN (US); (60) Provisional application No. 61/203,689, filed on Dec. Raymond E. Boucher, JR., 26, 2008. Lebanon, IN (US) Publication Classification (51) Int. Cl. Correspondence Address: AOIN 43/40 (2006.01) DOWAGROSCIENCES, LLC AOIP3/00 (2006.01) ONE INDIANA SQUARE, SUITE 2800 AOIP 7/04 (2006.01) INDIANAPOLIS, IN 46204-2079 (US) (52) U.S. Cl. ......................................... 514/336; 514/357 (57) ABSTRACT (73) Assignee: Dow AgroSciences, LLC Insect controlling compositions including an N-Substituted (6-haloalkylpyridin-3-yl)alkylsulfoximine compoundandan (21) Appl. No.: 12/633,987 organic acid or a salt thereof exhibit increased stability. US 2010/01 681 77 A1 Jul. 1, 2010 STABLE INSECTICDE COMPOSITIONS their use in controlling insects and certain other invertebrates, particularly aphids and other Sucking insects. This invention CROSS-REFERENCE TO RELATED also includes new synthetic procedures for preparing the APPLICATIONS compositions and methods of controlling insects using the 0001. The present application claims priority to U.S. Pro compositions. visional Patent Application No. 61/203,689 filed Dec. 26, 0007. This invention concerns compositions useful for the 2008, the content of which is incorporated herein by reference control of insects, especially useful for the control of aphids in its entirety. and other sucking insects. More specifically, the invention FIELD OF THE INVENTION concerns compositions including an organic acid or a salt thereof and a compound of the formula (I) 0002.
  • Dissociation Constants of Organic Acids and Bases

    Dissociation Constants of Organic Acids and Bases

    DISSOCIATION CONSTANTS OF ORGANIC ACIDS AND BASES This table lists the dissociation (ionization) constants of over pKa + pKb = pKwater = 14.00 (at 25°C) 1070 organic acids, bases, and amphoteric compounds. All data apply to dilute aqueous solutions and are presented as values of Compounds are listed by molecular formula in Hill order. pKa, which is defined as the negative of the logarithm of the equi- librium constant K for the reaction a References HA H+ + A- 1. Perrin, D. D., Dissociation Constants of Organic Bases in Aqueous i.e., Solution, Butterworths, London, 1965; Supplement, 1972. 2. Serjeant, E. P., and Dempsey, B., Ionization Constants of Organic Acids + - Ka = [H ][A ]/[HA] in Aqueous Solution, Pergamon, Oxford, 1979. 3. Albert, A., “Ionization Constants of Heterocyclic Substances”, in where [H+], etc. represent the concentrations of the respective Katritzky, A. R., Ed., Physical Methods in Heterocyclic Chemistry, - species in mol/L. It follows that pKa = pH + log[HA] – log[A ], so Academic Press, New York, 1963. 4. Sober, H.A., Ed., CRC Handbook of Biochemistry, CRC Press, Boca that a solution with 50% dissociation has pH equal to the pKa of the acid. Raton, FL, 1968. 5. Perrin, D. D., Dempsey, B., and Serjeant, E. P., pK Prediction for Data for bases are presented as pK values for the conjugate acid, a a Organic Acids and Bases, Chapman and Hall, London, 1981. i.e., for the reaction 6. Albert, A., and Serjeant, E. P., The Determination of Ionization + + Constants, Third Edition, Chapman and Hall, London, 1984. BH H + B 7. Budavari, S., Ed., The Merck Index, Twelth Edition, Merck & Co., Whitehouse Station, NJ, 1996.
  • Determination of Monochloroacetic Acid and Dichloroacetic Acid for Quality Control of Acetic Acid Chlorination Industry by Ion Chromatography

    Determination of Monochloroacetic Acid and Dichloroacetic Acid for Quality Control of Acetic Acid Chlorination Industry by Ion Chromatography

    Microchemical Journal 63, 317–321 (1999) Article ID mchj.1999.1759, available online at http://www.idealibrary.com on Determination of Monochloroacetic Acid and Dichloroacetic Acid for Quality Control of Acetic Acid Chlorination Industry by Ion Chromatography Feng Qu and Shifen Mou1 Research Center for Eco-Environmental Sciences, Academy of China, Beijing 100085 Received October 29, 1998; accepted June 1, 1999 An ion chromatographic method is described for the purpose of quality control in the process of monochloroacetic acid production. Using 2.5 mM NaOH–10% methanol as eluent, the simultaneous determination of acetic acid, monochloroacetic acid, dichloroacetic acid, and Cl2 was obtained in a single run. Monochloroacetic acid and dichloroacetic acid showed good linearity in the range 0.1–20 and 0.15–20 mg/ml and correlation coefficients were 0.9999 and 0.9998, respectively. The detection limits (signal-to-noise ratio 3:1) of monochloroacetic acid and dichloroacetic acid were 17 and 25 ng/ml. This simple, sensitive, and time-saving method can be applied for composition analysis in acetic acid chlorination production. © 1999 Academic Press Key Words: monochloroacetic acid; dichloroacetic acid; ion chromatography. INTRODUCTION The chloroacetic acid is an important industrial and commercial solvent. Acetic acid chlorination is the commonly used method for producing monochloroacetic acid (MCA). The reaction of acetic acid chlorination is 1 3 1 CH3COOH Cl2 ClCH2COOH HCl (1) 1 3 1 ClCH2COOH Cl2 Cl2CHCOOH HCl. (2) During the chlorinating process, the formation of dichloroacetic acid (DCA), the main by-product, not only increases the consumption of raw material but also lowers the quality and purity of MCA product.
  • NTP Annual Report

    NTP Annual Report

    2020 The Science of Substance ANNUAL REPORT FOR FISCAL YEAR 2020 The Science of Substance | 1. FY 2020 in Review I Contents 1.0 FY 2020 in Review 1 4.0 Science, Innovation, and Methods 1.1 Letter from the Director 2 Development 29 1.2 Timeline 4 4.1 Development of New Approach Methodologies 30 1.3 NTP Public Health Impact 5 NICEATM Activities 31 4.2 Tox21 40 2.0 About NTP 9 4.3 Validation and Adoption of NAMs 42 2.1 Organization and Structure 10 ICCVAM Test Method Evaluation Activities 43 2.2 Funding 12 ICCVAM International Validation Activities 44 Progress toward Strategic Roadmap Goals 46 3.0 Publishing, Collaboration, and Science Measuring Progress in Adopting Alternatives and Reducing Animal Use 47 Communications 1 5 3.1 Completed NTP Reports and Publications 16 5.0 Testing and Assessment 49 3.2 Advisory Groups 20 5.1 NTP at NIEHS/DNTP 52 3.3 Scientific Panels 21 5.1.1 Chemical Screening 52 3.4 Workshops and Meetings 22 5.1.2. Chemical Testing 55 NICEATM Meetings and Workshops 22 5.1.3 Noncancer Research 55 ICCVAM Meetings 24 5.1.4 Cancer Health Effects Research 56 3.5 Collaboration and Scientific Leadership 25 5.2 NTP at FDA/NCTR 60 FDA/NCTR 25 5.3 NTP at NIOSH 62 CDC/NIOSH 25 NIH/NCATS/DPI 26 DOE/ORNL 26 EPA/NCCT 26 EPA/NCEA 26 NIST 27 3.6 Training Opportunities 27 1.0 FY 2020 in Review The National Toxicology Program (NTP) annual report for fiscal year (FY) 2020 is titled The Science of Substance.
  • Dichloroacetic Acid (DCA) Pharma

    Dichloroacetic Acid (DCA) Pharma

    Safety Data Sheet Dichloroacetic Acid (DCA) Pharma 1. PRODUCT AND COMPANY IDENTIFICATION Product Name: Dichloroacetic Acid (DCA) Pharma Synonyms/Generic Names: Bichloroacetic acid; DCA Product Number: 1845 Product Use: Industrial, Manufacturing or Laboratory use Manufacturer: Columbus Chemical Industries, Inc. N4335 Temkin Rd. Columbus, WI. 53925 For More Information Call: 920-623-2140 (Monday-Friday 8:00-4:30) In Case of Emergency Call: CHEMTREC - 800-424-9300 or 703-527-3887 (24 Hours/Day, 7 Days/Week) 2. HAZARDS IDENTIFICATION OSHA Hazards: Corrosive, Harmful in contact with skin Target Organs: None Signal Word: Danger Pictograms: GHS Classification: Acute toxicity, Dermal Category 3 Skin corrosion Category 1A Serious eye damage Category 1 Carcinogenicity Category 2 Acute aquatic toxicity Category 1 GHS Label Elements, including precautionary statements: Hazard Statements: H311 Toxic in contact with skin. H314 Causes severe skin and eye damage. H351 Suspected of causing cancer. H401 Very toxic to aquatic life. Precautionary Statements: P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapors/spray. Revised on 08/02/2016 Page 1 of 6 P264 Wash hands thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection. P301+P330+P331 IF SWALLOWED: Rinse mouth. Do not induce vomiting. P303+P361+P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes.